Immunome (NASDAQ: IMNM) is expected to announce its Q4 2025 earnings on Wednesday, March 18, 2025, before the market opens. Analysts predict the company will report...
Kyverna Therapeutics, Inc. has announced plans to present topline results from its registrational Phase 2 clinical trial, known as KYSA-8, assessing the efficacy of its investigational...
The much-anticipated Holiday Collection from Stanley and LoveShackFancy officially launches today, November 12, 2023, at 12:00 p.m. ET. This collaboration introduces a range of drinkware that...
